|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
08156 SINOPHARM TECH
Nominal 
0.098 0.000 (0.000%) | 2023/06 - Final HKD(K$) | %Chg (Compare to Final) | 2022/06 HKD(K$) | 2021/06 HKD(K$) | 2020/06 HKD(K$) | 2019/06 HKD(K$) | |
| Turnover | 42,839 | 4.524% | 40,985 | 77,813 | 165,934 | 43,503 |
| Cost of Sales | (37,369) | 6.607% | (35,053) | (56,929) | (121,281) | (19,802) |
| Gross Profit | 5,470 | -7.788% | 5,932 | 20,884 | 44,653 | 23,701 |
| 2023/06 - Final HKD(K$) | %Chg (Compare to Final) | 2022/06 HKD(K$) | 2021/06 HKD(K$) | 2020/06 HKD(K$) | 2019/06 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | 1,815 | -- | -- | -- | (133,058) | (67,930) | |
| Profit / (Loss) on Disposal | (19,217) | -- | -- | -- | -- | -- | |
| Other Non-operating Items | (1,131) | -94.833% | (21,889) | (10,796) | -- | -- | |
| Share of Results of Asso. & JCEs | 186 | -- | (153) | 3,588 | 558 | 0 | |
| Profit / (Loss) before Taxation | (11,407) | -87.885% | (94,158) | (111,064) | (165,380) | (47,938) | |
| Taxation | 1,307 | 237.726% | 387 | 558 | 1,390 | 2,312 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (535) | -- | 5,773 | 4,166 | 2,915 | (1,170) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (10,635) | -87.914% | (87,998) | (106,340) | (161,075) | (46,796) | |
| 2023/06 - Final HKD(K$) | %Chg (Compare to Final) | 2022/06 HKD(K$) | 2021/06 HKD(K$) | 2020/06 HKD(K$) | 2019/06 HKD(K$) | |
| Net Finance Costs / (Income) | 8,569 | -47.772% | 16,407 | 14,545 | 18,150 | 11,935 |
| Depreciation & Amortisation | 2,007 | -17.271% | 2,426 | 10,454 | 9,269 | 11,102 |
| Directors' Emoluments | 4,248 | -51.407% | 8,742 | 4,939 | 10,600 | 10,638 |
| 2023/06 - Final | %Chg (Compare to Final) | 2022/06 | 2021/06 | 2020/06 | 2019/06 | |
| Auditor's Opinion Status | Qualified | -- | Qualified | Unqualified (Modified Report) | Unqualified (Modified Report) | Unqualified (Modified Report) |
Market Valuation Indicators
| 2023/06 - Final | %Chg (Compare to Final) | 2022/06 | 2021/06 | 2020/06 | 2019/06 | |
| EPS (cts) | -0.060 | -99.878% | -49.000 | -61.750 | -97.750 | -33.750 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | 0.026 | -- | (0.204) | (0.001) | 0.006 | (0.010) |
| NBV per share ($) | (0.940) | -- | (0.919) | (0.788377) | (0.425901) | 0.229602 |
| Remarks: | Real time quote last updated: 22/11/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders ($) | HKD -2,876,000 |
| %Change | -- |
| EPS / (LPS) | HKD -0.016 |
| NBV Per Share ($) | HKD -0.960 |